O’Brien, Christian
Souza, Carolina A. https://orcid.org/0000-0002-0321-734X
Sheikh, Adnan
Miguel, Olivier
Wood, Timothy
Article History
Received: 24 September 2020
Accepted: 10 December 2020
First Online: 6 January 2021
Ethics approval and consent to participate
: Ethics approval for this research project was granted by the Ottawa Health Science Network Research Ethics Board (OHSN-REB) with protocol ID: 20180726-01H.
: Carolina Souza: consultant fees and honorarium: Pfizer, Boehringer-Ingelheim, AstraZeneca, Hoffmann-La Roche. Advisory board: AstraZeneca, Boehringer-Ingelheim. Educational Grant: Boehringer-Ingelheim.Other authors: No declarations if interest.